1. Home
  2. PPBT vs AIMD Comparison

PPBT vs AIMD Comparison

Compare PPBT & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PPBT
  • AIMD
  • Stock Information
  • Founded
  • PPBT 2010
  • AIMD 1984
  • Country
  • PPBT Israel
  • AIMD United States
  • Employees
  • PPBT N/A
  • AIMD N/A
  • Industry
  • PPBT Biotechnology: Pharmaceutical Preparations
  • AIMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • PPBT Health Care
  • AIMD Health Care
  • Exchange
  • PPBT Nasdaq
  • AIMD Nasdaq
  • Market Cap
  • PPBT 8.7M
  • AIMD 8.5M
  • IPO Year
  • PPBT N/A
  • AIMD N/A
  • Fundamental
  • Price
  • PPBT $3.00
  • AIMD $0.62
  • Analyst Decision
  • PPBT Strong Buy
  • AIMD
  • Analyst Count
  • PPBT 2
  • AIMD 0
  • Target Price
  • PPBT $126.50
  • AIMD N/A
  • AVG Volume (30 Days)
  • PPBT 38.0K
  • AIMD 1.3M
  • Earning Date
  • PPBT 03-04-2025
  • AIMD 03-07-2025
  • Dividend Yield
  • PPBT N/A
  • AIMD N/A
  • EPS Growth
  • PPBT N/A
  • AIMD N/A
  • EPS
  • PPBT N/A
  • AIMD N/A
  • Revenue
  • PPBT N/A
  • AIMD $40,633.00
  • Revenue This Year
  • PPBT N/A
  • AIMD N/A
  • Revenue Next Year
  • PPBT N/A
  • AIMD N/A
  • P/E Ratio
  • PPBT N/A
  • AIMD N/A
  • Revenue Growth
  • PPBT N/A
  • AIMD N/A
  • 52 Week Low
  • PPBT $2.00
  • AIMD $0.40
  • 52 Week High
  • PPBT $20.60
  • AIMD $3.10
  • Technical
  • Relative Strength Index (RSI)
  • PPBT 40.77
  • AIMD 48.56
  • Support Level
  • PPBT $3.12
  • AIMD $0.57
  • Resistance Level
  • PPBT $3.37
  • AIMD $0.87
  • Average True Range (ATR)
  • PPBT 0.24
  • AIMD 0.09
  • MACD
  • PPBT -0.01
  • AIMD -0.02
  • Stochastic Oscillator
  • PPBT 21.93
  • AIMD 17.45

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

Share on Social Networks: